The aim of this study, therefore, has been to confirm the expression pattern of EGOT in breast cancer cells and adjacent tissues to explore the effects of abnormal expressions in lncRNA EGOT, along with the viability and migration of breast cancer cell lines and the Hh signaling pathway. The gene discussed is EGOT; the disease is breast cancer.